94 related articles for article (PubMed ID: 18163358)
1. Effect of alkyl-lysophospholipids on some aspects of the metabolism of Leishmania donovani.
Azzouz S; Maache M; Sánchez-Moreno M; Petavy AF; Osuna A
J Parasitol; 2007 Oct; 93(5):1202-7. PubMed ID: 18163358
[TBL] [Abstract][Full Text] [Related]
2. Aspects of the cytological activity of edelfosine, miltefosine, and ilmofosine in Leishmania donovani.
Azzouz S; Maache M; Dos Santos MF; Sarciron ME; Petavy AF; Osuna A
J Parasitol; 2006 Oct; 92(5):877-83. PubMed ID: 17152926
[TBL] [Abstract][Full Text] [Related]
3. Leishmanicidal activity of edelfosine, miltefosine and ilmofosine.
Azzouz S; Maache M; Garcia RG; Osuna A
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):60-5. PubMed ID: 15667597
[TBL] [Abstract][Full Text] [Related]
4. Study of the stress proteins secreted by Leishmania donovani after treatment with edelfosine, mitelfosine and ilmofosine, and morphological alterations analyzed by electronic microscopy.
Azzouz S; Maache M; Sarciron ME; Petavy AF; Osuna A
Parasite; 2009 Sep; 16(3):215-21. PubMed ID: 19839267
[TBL] [Abstract][Full Text] [Related]
5. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.
Santa-Rita RM; Henriques-Pons A; Barbosa HS; de Castro SL
J Antimicrob Chemother; 2004 Oct; 54(4):704-10. PubMed ID: 15329361
[TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani mitochondrial iron superoxide dismutase A is released into the cytosol during miltefosine induced programmed cell death.
Getachew F; Gedamu L
Mol Biochem Parasitol; 2012 May; 183(1):42-51. PubMed ID: 22342963
[TBL] [Abstract][Full Text] [Related]
7. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Croft SL; Snowdon D; Yardley V
J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
[TBL] [Abstract][Full Text] [Related]
8. Antiparasitic activity of a triphenyl tin complex against Leishmania donovani.
Raychaudhury B; Banerjee S; Gupta S; Singh RV; Datta SC
Acta Trop; 2005 Jul; 95(1):1-8. PubMed ID: 15896700
[TBL] [Abstract][Full Text] [Related]
9. Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.
Veronica J; Chandrasekaran S; Dayakar A; Devender M; Prajapati VK; Sundar S; Maurya R
FEBS J; 2019 Sep; 286(17):3488-3503. PubMed ID: 31087522
[TBL] [Abstract][Full Text] [Related]
10. Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species.
Das M; Saudagar P; Sundar S; Dubey VK
FEBS J; 2013 Oct; 280(19):4807-15. PubMed ID: 23890327
[TBL] [Abstract][Full Text] [Related]
11. Miltefosine affects lipid metabolism in Leishmania donovani promastigotes.
Rakotomanga M; Blanc S; Gaudin K; Chaminade P; Loiseau PM
Antimicrob Agents Chemother; 2007 Apr; 51(4):1425-30. PubMed ID: 17242145
[TBL] [Abstract][Full Text] [Related]
12. Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
Rakotomanga M; Saint-Pierre-Chazalet M; Loiseau PM
Antimicrob Agents Chemother; 2005 Jul; 49(7):2677-86. PubMed ID: 15980336
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.
Seifert K; Pérez-Victoria FJ; Stettler M; Sánchez-Cañete MP; Castanys S; Gamarro F; Croft SL
Int J Antimicrob Agents; 2007 Sep; 30(3):229-35. PubMed ID: 17628445
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity of perifosine against Leishmania amazonensis.
Cabrera-Serra MG; Valladares B; Piñero JE
Acta Trop; 2008 Oct; 108(1):20-5. PubMed ID: 18801328
[TBL] [Abstract][Full Text] [Related]
15. Novel Agents against Miltefosine-Unresponsive Leishmania donovani.
Das M; Saha G; Saikia AK; Dubey VK
Antimicrob Agents Chemother; 2015 Dec; 59(12):7826-9. PubMed ID: 26392497
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 16-mercaptohexadecylphosphocholine, a miltefosine analog with leishmanicidal activity.
Hornillos V; Saugar JM; de la Torre BG; Andreu D; Rivas L; Acuña AU; Amat-Guerri F
Bioorg Med Chem Lett; 2006 Oct; 16(19):5190-3. PubMed ID: 16870434
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo interactions between miltefosine and other antileishmanial drugs.
Seifert K; Croft SL
Antimicrob Agents Chemother; 2006 Jan; 50(1):73-9. PubMed ID: 16377670
[TBL] [Abstract][Full Text] [Related]
18. Ether--lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether--lipid analogues in Leishmania.
Lux H; Heise N; Klenner T; Hart D; Opperdoes FR
Mol Biochem Parasitol; 2000 Nov; 111(1):1-14. PubMed ID: 11087912
[TBL] [Abstract][Full Text] [Related]
19. Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance.
Pérez-Victoria FJ; Gamarro F; Ouellette M; Castanys S
J Biol Chem; 2003 Dec; 278(50):49965-71. PubMed ID: 14514670
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca
Pinto-Martinez AK; Rodriguez-Durán J; Serrano-Martin X; Hernandez-Rodriguez V; Benaim G
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
